Nuevas aproximaciones terapéuticas para la Enfermedad de Alzheimer: inhibidores de PDE5
Previous studies have demonstrated that cognitive function can be restored in mouse models of Alzheimer¿s disease (AD) following administration of sildenafil, a specific PDE5 inhibitor. Another very potent PDE5 inhibitor with a longer half-life and safe in chronic treatments, tadalafil, may represen...
Main Authors: | Garcia-Barroso, C. (C.), Cuadrado-Tejedor, M. (Mar), Garcia-Osta, A. (Ana) |
---|---|
Format: | info:eu-repo/semantics/doctoralThesis |
Language: | spa |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/40926 |
Similar Items
-
Identification of novel therapeutic strategies for Alzheimer’s disease
by: Pérez-González, M. (Marta), et al.
Published: (2019) -
Targeting JNK for the diagnosis and treatment of Alzheimer's disease
by: Vela-Lumbreras, S. (Silvia), et al.
Published: (2018) -
The compound 33i, a new SIRT2 inhibitor, as a potential treatment for Alzheimer’s disease
by: Díaz-Perdigón, T. (Teresa), et al.
Published: (2019) -
Adrenomedullin, a new therapeutic target for the treatment of Alzheimer's disease
by: Ferrero-Hidalgo, H. (Hilda), et al.
Published: (2018) -
Imaging and therapy of brain cancer using theranostic nanoparticles
by: Luque-Michel, E. (Edurne), et al.
Published: (2019)